Tuesday’s World #3: Venezuela

Tuesday's World Events   —   Posted on April 17, 2018

(by Kejal Vyas and Ryan Dube, The Wall Street Journal) – …Venezuelan President Nicolás Maduro’s cash-strapped Socialist regime prohibits most international humanitarian donations—including contributions of lifesaving medicines—except from a few remaining allies such as Russia.

The authoritarian leader and his lieutenants have denied the country is in a humanitarian crisis and they consider international aid part of a ploy by the U.S. and political rivals to besmirch the government and open the door to foreign intervention.

“No way are we going to allow this right-wing to impose a supposed humanitarian aid when our people are already being tended to by President Maduro,” Venezuela’s Health Minister Luis Lopez said in December.

Public health has deteriorated sharply in what used to be one of Latin America’s richest nations. Venezuela’s infant mortality rate was higher than in Syria in 2016, according to Health Ministry figures. Cases of diphtheria and malaria, diseases controlled by most Latin American nations, have increased amid a lack of vaccinations, the ministry said.

Venezuela’s Socialist President Nicolas Maduro

“The situation is complicated, I think that is a point that we all agree on due to the social, political and economic issues,” said Jose Moya, a Peruvian doctor who is the representative in Venezuela for the Pan American Health Organization, a branch of the World Health Organization. “This has really affected the purchase of supplies, the functioning of hospitals, [and] it is affecting the availability of medicine.”

In March, the U.S. Treasury sanctioned Carlos Rotondaro, former head of the government’s Social Security Institute, which is responsible for providing drugs for chronic illnesses. The U.S. said mishandling of health care by him and others has contributed to outbreaks of once-controlled diseases like diphtheria and measles. Mr. Rotondaro couldn’t be reached for comment.

“We have a scarcity of almost 100% of medicines and what is available, people cannot afford,” said Feliciano Reyna, head of a Caracas-based health advocacy group, Solidarity Action, which has tried to open the country to international medical aid. “We are seeing more and more deaths and suffering.”

Patients with transplants are particularly vulnerable because of the risk that their bodies will reject the new organs, an outcome immune system-suppressing drugs can help prevent. There are about 3,500 transplant patients—most of them kidney recipients—in Venezuela, according to health-advocacy groups.

The government’s transplant program was suspended in mid-2017 because of financial troubles, leaving 5,000 patients who await new kidneys in limbo, advocacy groups say.

Without anti-rejection drugs, an organ can deteriorate in as little as 48 hours. A patient rejects a transplanted organ every two days in Venezuela, according to the Caracas-based health-sector watchdog Codevida.

The malnutrition now common in Venezuela means patients also face higher risks for organ rejection, said Dr. Luis Hernández, a nephrologist at University Hospital in Caracas.

“We have to help the people,” said Dr. Hernández, who said he has called on the government to accept international aid.

In January, the Pan American Health Organization (PAHO) said it helped Venezuela purchase 135,000 pills of the immunosuppressive drug tacrolimus at a discount. But that covers just one of several medications that doctors prescribe to transplant patients, activists say.

Last year, PAHO signed an agreement with Venezuela’s Social Security Institute that allows it to purchase immunosuppressive drugs at a discount. About 500,000 pills of another immunosuppressive drug called mycophenolate are expected to be delivered in April, PAHO’s Dr. Moya said.

In addition, PAHO has used its own funds to purchase drugs for Venezuela, Dr. Moya said, while acknowledging the supply is insufficient for Venezuelan transplant patients. “They are quantities that guarantee a few weeks, months of treatment, so we have to continue working to get the medicine,” he said.

Dr. Moya said his office has been in contact with foreign nations that have expressed interest in providing support through PAHO to supply more immunosuppressive drugs.

Individual donors also want to help, including people associated with a federation that stages athletic contests around the world for transplant recipients. Rodolfo Wetzel, former president of a group of transplant athletes in Argentina, said he has about 50 boxes of immunosuppressive drugs ready for delivery. In Bulgaria, Stoyanka Ananieva, a former federation council member whose daughter received a kidney transplant, said she is collecting medicines she wants to send to Venezuela.

But they say they haven’t shipped the drugs out of fear the materials could be seized at Venezuela’s ports. Small packages that enter with individual travelers aren’t enough to satisfy demand, activists say.

“It’s a situation of helplessness,” said Mr. Wetzel.

Patients nationwide are improvising, taking long-expired medicines or waiting for unused pills to be passed down as people die. Because of shortages of steroids, which transplant patients also often take, some are turning to steroids veterinarians prescribe for household pets. …..

Mayela Armas in Caracas contributed to this article.

Published at WSJ on April 6. Reprinted here for educational purposes only. May not be reproduced on other websites without permission from The Wall Street Journal.